CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 163331-163485 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T33219","span":{"begin":0,"end":154},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"7/37 (18.9%) PT samples were negative for MRD by all assays, and 6/7 (85.7%) of these patients remained diseasefree with a median follow-up of 3.5 months."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T311","span":{"begin":0,"end":154},"obj":"Sentence"}],"text":"7/37 (18.9%) PT samples were negative for MRD by all assays, and 6/7 (85.7%) of these patients remained diseasefree with a median follow-up of 3.5 months."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1033","span":{"begin":42,"end":45},"obj":"Disease"},{"id":"T70897","span":{"begin":42,"end":45},"obj":"Disease"}],"attributes":[{"id":"A1033","pred":"mondo_id","subj":"T1033","obj":"http://purl.obolibrary.org/obo/MONDO_0019982"},{"id":"A17151","pred":"mondo_id","subj":"T70897","obj":"http://purl.obolibrary.org/obo/MONDO_0019982"}],"text":"7/37 (18.9%) PT samples were negative for MRD by all assays, and 6/7 (85.7%) of these patients remained diseasefree with a median follow-up of 3.5 months."}